OBJECTIVES: Psychological interventions show greater efficacy when evaluated with distressed patients. We report on the feasibility of implementing screening for recruiting distressed cancer patients to a randomized controlled trial of problem-solving therapy (PST), characteristics associated with enrolment, and time investment and challenges of implementing screening. METHODS: Three medical settings implemented screening of patients, directly after cancer treatment (T1) and 2 months later (T2), using Hopkins Symptom Checklist-25 and one question about need for services. Distressed patients indicating need for services were interviewed. Eligible patients were offered the possibility to participate in the trial. Consenting patients were randomized to PST or waitlist. RESULTS: At T1, 366 of 970 screened patients (37%) scored above the cutoff and at T2, 208 of 689 screened patients (30%). At either or both T1 and T2, 423 patients reported distress, of whom 215 indicated need for services. Only 36 (4% of 970) patients consented to trial participation. Twenty-seven patients needed to be screened to recruit a single patient, with 17 h required for each patient recruited. Barriers to screening were time constraints and negative attitudes of oncology staff towards screening. CONCLUSIONS: Implementing screening proved inefficient for recruiting distressed cancer patients post-treatment to a randomized controlled trial on PST, with need for services being much less than anticipated. Consecutively screening patients did not result in a sample representative of the larger pool of distressed patients, which may lower generalizability. An adequately powered intervention trial using screening requires a feasibility study establishing recruitment rates and dedicated, funded staff assistance.
RCT Entities:
OBJECTIVES: Psychological interventions show greater efficacy when evaluated with distressed patients. We report on the feasibility of implementing screening for recruiting distressed cancerpatients to a randomized controlled trial of problem-solving therapy (PST), characteristics associated with enrolment, and time investment and challenges of implementing screening. METHODS: Three medical settings implemented screening of patients, directly after cancer treatment (T1) and 2 months later (T2), using Hopkins Symptom Checklist-25 and one question about need for services. Distressed patients indicating need for services were interviewed. Eligible patients were offered the possibility to participate in the trial. Consenting patients were randomized to PST or waitlist. RESULTS: At T1, 366 of 970 screened patients (37%) scored above the cutoff and at T2, 208 of 689 screened patients (30%). At either or both T1 and T2, 423 patients reported distress, of whom 215 indicated need for services. Only 36 (4% of 970) patients consented to trial participation. Twenty-seven patients needed to be screened to recruit a single patient, with 17 h required for each patient recruited. Barriers to screening were time constraints and negative attitudes of oncology staff towards screening. CONCLUSIONS: Implementing screening proved inefficient for recruiting distressed cancerpatients post-treatment to a randomized controlled trial on PST, with need for services being much less than anticipated. Consecutively screening patients did not result in a sample representative of the larger pool of distressed patients, which may lower generalizability. An adequately powered intervention trial using screening requires a feasibility study establishing recruitment rates and dedicated, funded staff assistance.
Authors: Sylvie D Lambert; Patrick McElduff; Afaf Girgis; Janelle V Levesque; Tim W Regan; Jane Turner; Hayley Candler; Cathrine Mihalopoulos; Sophy T F Shih; Karen Kayser; Peter Chong Journal: Support Care Cancer Date: 2015-07-17 Impact factor: 3.603
Authors: L Leermakers; S Döking; B Thewes; A M J Braamse; M F M Gielissen; J H W de Wilt; E H Collette; J Dekker; J B Prins Journal: BMC Cancer Date: 2018-07-18 Impact factor: 4.430
Authors: Belinda Thewes; Judith A C Rietjens; Sanne W van den Berg; Félix R Compen; Harriet Abrahams; Hanneke Poort; Marieke van de Wal; Melanie P J Schellekens; Marlies E W J Peters; Anne E M Speckens; Hans Knoop; Judith B Prins Journal: Psychooncology Date: 2018-06-29 Impact factor: 3.894
Authors: Jacques J D M van Lankveld; Joke Fleer; Maya J Schroevers; Robbert Sanderman; Brenda L den Oudsten; Joost Dekker Journal: Psychooncology Date: 2018-06-29 Impact factor: 3.894
Authors: L J van der Donk; J Fleer; R Sanderman; P M G Emmelkamp; T P Links; K A Tovote; M J Schroevers Journal: PLoS One Date: 2019-02-14 Impact factor: 3.240
Authors: Loek J van der Donk; K Annika Tovote; Thera P Links; Jan L N Roodenburg; Johanna C Kluin-Nelemans; Henriette J G Arts; Veronique E M Mul; Robert J van Ginkel; Peter C Baas; Christiaan Hoff; Robbert Sanderman; Joke Fleer; Maya J Schroevers Journal: Psychooncology Date: 2019-03-05 Impact factor: 3.894
Authors: Eva Rames Nissen; Robert Zachariae; Maja O'Connor; Viktor Kaldo; Carsten René Jørgensen; Inger Højris; Michael Borre; Mimi Mehlsen Journal: Internet Interv Date: 2021-01-14
Authors: Emanuela Offidani; Janey C Peterson; Joseph Loizzo; Anne Moore; Mary E Charlson Journal: J Evid Based Complementary Altern Med Date: 2017-05-17